Company
NASDAQ · NASDAQ:UBX
Unity Biotechnology
Longevity exposure
How this company touches longevity
Senolytics, clearing senescent cells.
Recent inflection
What moved lately
Lead UBX1325 Ph2b FAILED Apr 2026; senolytic thesis impaired.
Keep reading
Related coverage from the newsroom.
Every entity profile on variis is sourced. Not investment advice.